fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd

Updated on November 23, 2020

Stock/Share Code - SPARC

Sun Pharma Advanced Research Company is in the business of research & development of pharmaceutical products.

Below is the details of SPARC Sun Pharma Advanced Research Company Ltd

Market Cap₹4,721 Cr.
Current Price ₹181.7 as on 27 Nov 20
52 Week High / Low Price₹210.9 / ₹81
Face Value₹1
Stock P/E
Book Value-₹0.71
Dividend Yield0.00 %
ROCE-178 %
ROE-225 %
Sales Growth (3yrs)-24.85 %
SectorMiscellaneous
IndustryMiscellaneous
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company is expected to give good quarter
Cons: Company has low interest coverage ratio. The company has delivered a poor growth of -13.18% over past five years. Company has a low return on equity of -129.08% for last 3 years. Debtor days have increased from 59.49 to 76.26 days.

Sun Pharma Advanced Research Company Ltd Price Chart

Sun Pharma Advanced Research Company Ltd Price Chart

Sun Pharma Advanced Research Company Ltd Peer Comparison in Miscellaneous

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Gujarat Gas ₹348.85 21.88 ₹22,403.66 Cr. 0.38 ₹59.07 Cr. -74.76 -58.58 1082.92 29.09
2. Multi Comm. Exc. ₹1.25 32.71 ₹8,151.84 Cr. 1.88 ₹56.43 Cr. 29.13 -8.11 73.01 18.72
3. Affle India ₹3,418.5 90.79 ₹6,454.92 Cr. 0.00 ₹18.77 Cr. 42.30 20.37 89.77 42.67
4. Indian Energy Ex ₹217.7 31.88 ₹5,776.95 Cr. 1.30 ₹42.88 Cr. 8.31 9.51 66.31 57.04
5. Security & Intel ₹36 25.72 ₹5,337.68 Cr. 0.55 ₹57.1 Cr. -23.89 7.88 2166.73 18.16
6. SPARC ₹4,726.03 Cr. 0.00 ₹56.69 Cr. 160.19 970.73 185.45 -178.50
7. C D S L ₹11 34.03 ₹4,249.49 Cr. 1.06 ₹46.16 Cr. 68.28 11.76 65.27 19.59

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sun Pharma Advanced Research Company Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -1519201761208517172023185
YOY Sales Growth %-84%-16%-52%-28%299%2%322%3%-72%-1%-73%971%
Expenses -777865816790971128073121125
Material Cost %6.45%27.03%25.63%17.13%3.34%23.19%3.52%58.55%25.54%25.05%19.77%3.36%
Employee Cost %173.70%127.29%120.96%121.53%32.50%107.44%22.79%130.89%135.43%116.12%107.35%12.94%
Operating Profit-61-58-45-64-5-70-12-95-63-54-9861
OPM %-400%-300%-224%-379%-8%-354%-14%-549%-366%-274%-433%33%
Other Income1250153442131
Interest000000010022
Depreciation222222222233
Profit before tax-63-582-64-3-69-9-94-63-56-10057
Tax %0%0%0%0%0%0%0%0%0%0%0%0%
Net Profit-63-582-64-3-69-9-94-63-56-10057
EPS in Rs-2.53-2.340.10-2.57-0.10-2.72-0.37-3.59-2.41-2.12-3.802.16
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -35345829871671561611817818377245
Sales Growth %-6%-2%70%-50%201%91%-7%4%12%-57%134%-58%
Expenses -45536599104134191224304321334387399
Material Cost %22%20%13%26%11%5%6%12%14%34%7%31%
Manufacturing Cost %22%22%14%30%12%7%80%82%83%168%89%-0%
Employee Cost %47%64%44%105%42%24%29%35%47%129%44%121%
Other Cost %39%49%41%181%55%44%7%11%25%79%42%297%
Operating Profit-10-19-7-70-1734-35-63-123-243-151-310-154
OPM %-29%-56%-11%-241%-19%20%-23%-39%-68%-310%-83%-404%-63%
Other Income-001121033145414107
Interest0000460220034
Depreciation23333478888910
Profit before tax-12-22-8-72-2234-40-70-119-197-145-312-162
Tax %27%-0%0%0%0%12%0%0%0%0%0%0%
Net Profit-9-22-8-72-2230-40-70-119-197-145-312-162
EPS in Rs0.000.000.000.000.001.230.000.000.000.000.00-11.92-6.17
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Compounded Sales Growth

  • 10 Years:: 8.40%
  • 5 Years:: -13.18%
  • 3 Years:: -24.85%
  • TTM:: 33.58%

Compounded Profit Growth

  • TTM:: 7.78%

Return on Equity

  • 10 Years:: 6.86%
  • 5 Years:: -13.14%
  • 3 Years:: -22.56%
  • 1 Year:: 12.63%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -212121212424242425252626
Equity Capital20.7120.7120.7120.7123.6623.6723.6723.6724.6925.0926.2126.21
Reserves15-7-15-8785116766133160270-45
Borrowings2276881545632268
Other Liabilities -2456668420393977111122101223
Trade Payables7111016133027589410283159
Advance from Customers124252520003330
Other liability items5331679121614161765
Total Liabilities62727886209184143163273309398273
Fixed Assets -5361636466646770695258132
Gross Block60717580858796107776780
Accumulated Depreciation71013161922303781523
CWIP4211010113244
Investments002097600101082118
Other Assets -491121461127692192146106128
Trade receivables1034252820939181016
Cash Equivalents155677171370110
Loans n Advances171827288946676349361
Other asset items-14-1512-14-12-83207959111
Total Assets62727886209184143163273309398273

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -25132-69-9537-41-44-128-183-172-211
Profit from operations-10-18-6-69-1735-35-61-120-242-167-303
Receivables25-1-2-2-20-3811-30217-6
Payables1131107-317-331368-1972
Loans Advances-0-0-0-5-4-4-13-16-0-0-0-0
Other WC items-0-0-0-0-500447-91236
Working capital changes363081-7810-4301320-0102
Direct taxes-0-0-0-1-1-8-3-14-21-10-5-10
Other operating items-00-0-0-0-0-0-0-049-0-0
Cash from Investing Activity --26-12-8-2-994453-13-7-105-102155
Fixed assets purchased-26-8-5-5-4-4-8-12-9-33-13-54
Fixed assets sold0000000101500
Investments purchased00-110-173-589-38-17-37-94-940
Investments sold00907768445172800209
Interest received0001124111130
Inter corporate deposits00000-505000000
Other investing items0-4-11-0-0-0-20610
Cash from Financing Activity -10472194-81-15119422427455
Proceeds from shares00001871002501333670
Proceeds from borrowings12463783104900060
Repayment of borrowings0-20-1-70-102-13000-3
Interest paid fin-0-0-0-0-1-9-0-2-3-0-0-2
Share application money0001100020000
Other financing items000-10-10-1-5391-92-0
Net Cash Flow01-10-0-011-760-6300

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %-29%-79%-59%-1,034%-20%21%-32%-71%-95%-143%-61%-178%
Debtor Days55165410561472178822076
Inventory Turnover

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sun Pharma Advanced Research Company Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.